Sunscreen Innovation Act Starts Clock Ticking On FDA Review Of TEAs

Congress passes legislation to streamline FDA’s process for reviewing UV filter TEA submissions. The bill’s passing during Congress’ lame duck session reflects not only bipartisan support, but also lobbying by the personal-care product industry and consumer-health advocates to impose deadlines on FDA for long-sought changes to the OTC drug sunscreen monograph.

More from Archive

More from HBW Insight